(Q51528519)

6 April 2018

title

Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes. (English)

1 reference

6 April 2018

1 reference

Manouchehr Nakhjavani

1

1 reference

6 April 2018

Afsaneh Morteza

2

1 reference

6 April 2018

Alireza Esteghamati

3

1 reference

6 April 2018

Omid Khalilzadeh

4

1 reference

6 April 2018

Ali Zandieh

5

1 reference

6 April 2018

Reza Safari

6

1 reference

6 April 2018

publication date

14 December 2010

1 reference

6 April 2018

published in

Lipids

1 reference

6 April 2018

volume

46

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

349-356

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s11745-010-3513-1

exact match

0 references

cites work

Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control

1 reference

12 December 2020

High lipoprotein(a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases

1 reference

12 December 2020

Increased levels of lipoprotein(a) in non-smoking aortic dissection patients

1 reference

12 December 2020

Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?

1 reference

12 December 2020

The relationship between lipoprotein(a) and the complications of diabetes mellitus

1 reference

12 December 2020

Impact of glycemic control on serum lipoprotein (a) in Arab children with type 1 diabetes

1 reference

12 December 2020

Estrogen attenuates vascular remodeling in Lp(a) transgenic mice

1 reference

12 December 2020

High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.

1 reference

12 December 2020

Menopause is an independent predictor of metabolic syndrome in Iranian women

1 reference

12 December 2020

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data

1 reference

12 December 2020

[Selected parameters of lipoprotein metabolism in cerebrovascular diseases]

1 reference

12 December 2020

Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality.

1 reference

12 December 2020

Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women

1 reference

12 December 2020

Gender difference in hipolipemic and anti-inflammatory effects of statins in diabetics with coronary artery disease

1 reference

12 December 2020

Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns

1 reference

12 December 2020

Dyslipidemia in type 2 diabetes mellitus

1 reference

12 December 2020

Gender-specific care of the patient with diabetes: review and recommendations

1 reference

12 December 2020

Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees

1 reference

12 December 2020

Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus

1 reference

12 December 2020

Cardiovascular events in patients with increased lipoprotein (a) - retrospective data analysis in an outpatient department of lipid disorders

1 reference

12 December 2020

Lipoprotein(a) and its position among other risk factors of atherosclerosis

1 reference

12 December 2020

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study

1 reference

12 December 2020

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study

1 reference

12 December 2020

Metabolic syndrome and mortality in stable coronary heart disease: relation to gender.

1 reference

12 December 2020

Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease

1 reference

12 December 2020

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

1 reference

12 December 2020

Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size

1 reference

12 December 2020

Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women

1 reference

12 December 2020

Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women

1 reference

12 December 2020

Lipoprotein(a) in android obesity and NIDDM.

1 reference

12 December 2020

Magnitude of lipoprotein (a) in diabetes mellitus.

1 reference

12 December 2020

Lp(a) lipoprotein, vascular disease, and mortality in the elderly

1 reference

12 December 2020

Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.

1 reference

12 December 2020

Influence of menopause on diabetes and diabetes risk

1 reference

12 December 2020

1 reference

12 December 2020

Lipoprotein heterogeneity at birth: influence of gestational age and race on lipoprotein subclasses and Lp (a) lipoprotein.

1 reference

12 December 2020

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

1 reference

12 December 2020

Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events

1 reference

12 December 2020

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

12 December 2020

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

1 reference

12 December 2020

Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients

1 reference

12 December 2020

Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study

1 reference

12 December 2020

Association of serum lipoprotein (a) with hypertension in diabetic patients.

1 reference

12 December 2020

Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5-11 y.

1 reference

12 December 2020

Diabetes and decline in heart disease mortality in US adults.

1 reference

12 December 2020

10.1007/S11745-010-3513-1

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21153771

1 reference

6 April 2018